Monarch Medical Technologies
Monarch Medical Technologies is a digital health company dedicated to advancing glycemic management in hospitals through innovative solutions like the FDA-cleared EndoTool Glucose Management System. With over 20 years of experience, they focus on empowering healthcare providers with safe, effective, and patient-centric glycemic management tools. Their mission is to improve inpatient diabetes care by providing evidence-based, integrated, and innovative insulin dosing solutions, supported by clinical research, white papers, and a strong advisory board.
Industries
Nr. of Employees
small (1-50)
Monarch Medical Technologies
Monarch Medical Technologies, 1234 Innovation Drive, City, State, ZIP
Patents
Products
Patient-specific inpatient insulin dosing software (IV and subcutaneous)
Clinical decision support application that provides individualized insulin dosing recommendations for IV and subcutaneous therapy using patient lab values, clinical characteristics and adaptive models; integrates with hospital EMRs and includes analytics for outcomes monitoring.
Patient-specific inpatient insulin dosing software (IV and subcutaneous)
Clinical decision support application that provides individualized insulin dosing recommendations for IV and subcutaneous therapy using patient lab values, clinical characteristics and adaptive models; integrates with hospital EMRs and includes analytics for outcomes monitoring.
Services
Design and implement HL7 interfaces and HTML-based application launches to exchange patient, lab, order and result data with hospital EMRs; includes integration of device data streams where applicable.
Project management, clinician training and multidisciplinary implementation support including formation of glycemic management committees, gap analyses and protocol development for monitoring and dosing workflows.
Analytics, dashboards and reporting to track unit-level glycemic performance, hypoglycemia/hyperglycemia events, support CMS eCQM submission and benchmarking, and analyze continuous glucose data where available.
Collaborative support for clinical studies, case study development and dissemination of results demonstrating clinical and economic outcomes related to glycemic management interventions.
Advisory services related to regulatory submissions, quality management system alignment and compliance with standards relevant to medical device software (including ISO 13485 and FDA 510(k) pathways).
Engagement with clinical experts to inform product design, clinical protocols, evidence generation and implementation best practices.
Design and implement HL7 interfaces and HTML-based application launches to exchange patient, lab, order and result data with hospital EMRs; includes integration of device data streams where applicable.
Project management, clinician training and multidisciplinary implementation support including formation of glycemic management committees, gap analyses and protocol development for monitoring and dosing workflows.
Analytics, dashboards and reporting to track unit-level glycemic performance, hypoglycemia/hyperglycemia events, support CMS eCQM submission and benchmarking, and analyze continuous glucose data where available.
Collaborative support for clinical studies, case study development and dissemination of results demonstrating clinical and economic outcomes related to glycemic management interventions.
Advisory services related to regulatory submissions, quality management system alignment and compliance with standards relevant to medical device software (including ISO 13485 and FDA 510(k) pathways).
Engagement with clinical experts to inform product design, clinical protocols, evidence generation and implementation best practices.
Expertise Areas
- Inpatient glycemic management
- Clinical decision support for insulin dosing
- EMR interoperability and HL7 integration
- Clinical analytics and quality measurement for glycemic outcomes
Key Technologies
- Model predictive control algorithms
- Machine-learning adaptive dosing models
- HL7 bi-directional interfacing (ADT, ORM, ORU, pharmacy/admin messages)
- Continuous glucose monitoring data ingestion and trend analytics
News & Updates
The company announced the formation of its Clinical Advisory Board comprising experts from diverse medical disciplines to guide innovation and clinical efficacy.
An overview of how EndoTool and other technologies support hospitals in meeting ADA standards for inpatient diabetes management.
FDA Clearance for EndoTool SubQ Insulin Dosing System
EndoTool received FDA clearance for its enhanced software for inpatient subcutaneous insulin management, addressing challenges in insulin dosing and improving patient safety.
Implementation of EndoTool in Major Hospitals
Numerous hospitals across the US have successfully integrated EndoTool, demonstrating its efficacy in improving glycemic outcomes and reducing hypoglycemia.
Monarch Medical Technologies Achieves ISO 13485 Certification
Monarch Medical Technologies has earned ISO 13485:2016 certification, affirming its commitment to quality management systems for medical devices.
Monarch Medical Technologies Announces FDA Clearance of EndoTool IV 3.1 with Dosing Mode For Hyperglycemic Crisis Management
Strengthening hospital response to hyperglycemic crises, including conditions such as Euglycemic DKA, DKA, and HHNK, with FDA-cleared EndoTool IV 3.1.
The company announced the formation of its Clinical Advisory Board comprising experts from diverse medical disciplines to guide innovation and clinical efficacy.
An overview of how EndoTool and other technologies support hospitals in meeting ADA standards for inpatient diabetes management.
FDA Clearance for EndoTool SubQ Insulin Dosing System
EndoTool received FDA clearance for its enhanced software for inpatient subcutaneous insulin management, addressing challenges in insulin dosing and improving patient safety.
Implementation of EndoTool in Major Hospitals
Numerous hospitals across the US have successfully integrated EndoTool, demonstrating its efficacy in improving glycemic outcomes and reducing hypoglycemia.
Monarch Medical Technologies Achieves ISO 13485 Certification
Monarch Medical Technologies has earned ISO 13485:2016 certification, affirming its commitment to quality management systems for medical devices.
Monarch Medical Technologies Announces FDA Clearance of EndoTool IV 3.1 with Dosing Mode For Hyperglycemic Crisis Management
Strengthening hospital response to hyperglycemic crises, including conditions such as Euglycemic DKA, DKA, and HHNK, with FDA-cleared EndoTool IV 3.1.